These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1618887)

  • 41. The development of cell mediated immunity: very young children have strong LAK activity.
    Pierson GR; Evans AE; Zier KS
    J Clin Lab Immunol; 1990 Feb; 31(2):51-4. PubMed ID: 1966985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 2 and alpha interferon induced in vitro modulation of spontaneous cell mediated cytotoxicity in patients with cancer of the uterine cervix undergoing radiotherapy.
    Radhakrishna Pillai M; Balaram P; Padmanabhan TK; Abraham T; Krishnan Nair M
    Acta Oncol; 1989; 28(1):39-44. PubMed ID: 2784974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
    Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
    Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
    Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
    Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors.
    Yamamoto M; Saigo K; Koshiba M; Kitamura N; Horie O; Ryo R; Kumagai S
    Haematologia (Budap); 2002; 32(2):103-11. PubMed ID: 12412729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
    J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of cryopreservation on activity and surface markers of lymphokine-activated killer cells.
    Letellier C; Rameliarison L; Fizet D; Ferrer AM; Vezon G
    Vox Sang; 1991; 61(2):90-5. PubMed ID: 1763504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of human NK cells and generation of LAK activity.
    Whiteside TL
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines.
    Jackson AM; Hawkyard SJ; Prescott S; Ritchie AW; James K; Chisholm GD
    J Urol; 1992 Jan; 147(1):207-11. PubMed ID: 1729534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological effects of flavone acetic acid.
    Triozzi PL; Rinehart JJ; Malspeis L; Young DC; Grever MR
    Cancer Res; 1990 Oct; 50(20):6483-5. PubMed ID: 2208107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Noguchi K; Arii K; Hotta T
    Nihon Geka Hokan; 1991 Nov; 60(6):396-405. PubMed ID: 1820012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells.
    Knight CR; Rees RC; Platts A; Johnson T; Griffin M
    Immunology; 1993 Aug; 79(4):535-41. PubMed ID: 8104887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids.
    Purasiri P; Mckechnie A; Heys SD; Eremin O
    Immunology; 1997 Oct; 92(2):166-72. PubMed ID: 9415022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of NK cells through the 80-kDa TNFR (CD120b).
    Mason AT; McVicar DW; Smith CA; Young HA; Ware CF; Ortaldo JR
    J Leukoc Biol; 1995 Aug; 58(2):249-55. PubMed ID: 7543923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin.
    Shau H; Kim A; Golub SH
    J Leukoc Biol; 1992 Apr; 51(4):343-9. PubMed ID: 1564398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part II. Immunedefense suppressive effects of the CRISPPs peptide.
    Cercek L; Cercek B
    Cancer Detect Prev; 1993; 17(3):433-45. PubMed ID: 7691405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells.
    Ozdemir O; Savaşan S
    Clin Immunol; 2005 Jun; 115(3):240-9. PubMed ID: 15893691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.